PNC Financial Services Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
PNC Financial Services Group's OVID Position: Q3 2026 in Review
PNC Financial Services Group held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 903 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4792.
PNC Financial Services Group first reported a position in OVID in Q2 2022 and has held it in 11 quarters since. The position peaked at $4K in Q3 2022. 129 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- PNC Financial Services Group held 903 shares of Ovid Therapeutics worth $2.25K as of Q3 2026.
- PNC Financial Services Group left its Ovid Therapeutics share count unchanged in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4792 holding.
- PNC Financial Services Group first reported a position in Ovid Therapeutics in Q2 2022 and has held it in 11 quarters since.
- PNC Financial Services Group's Ovid Therapeutics position peaked at $4K in Q3 2022.
- 129 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.